Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jansen

Showing results (1501-1510 of 1,668) with videos related to

Pageof 167
Sort By:
Endoscopy|July 6, 2025
Two-sample fecal immunochemical testing as a tool to avert colonoscopy in symptomatic patients: a prospective multicenter cohort studySarah Moen, Pieter H A Wisse, Fleur Marijnissen, et al.
The Lancet. Gastroenterology & Hepatology|February 3, 2023
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trialReinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
Molecular Oncology|July 28, 2019
RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancerErik J van Helden, Lindsay Angus, C Willemien Menke-van der Houven van Oordt, et al.
NPJ Precision Oncology|November 6, 2022
Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patientsTessa J J de Bitter, Philip R de Reuver, Elise A J de Savornin Lohman, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2022
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysisFrederik O Meeuwes, Mirian Brink, Marjolein W M van der Poel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2021
IL-7 and IL-15 Levels Reflect the Degree of T Cell Depletion during Lymphopenia and Are Associated with an Expansion of Effector Memory T Cells after Pediatric Hematopoietic Stem Cell TransplantationKatrine Kielsen, Lisa V E Oostenbrink, Erik G J von Asmuth, et al.
Breast Cancer Research and Treatment|March 4, 2008
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifenMarleen Kok, Sabine C Linn, Ryan K Van Laar, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
NPJ Digital Medicine|May 15, 2025
Reducing outpatient visits for FIT-positive participants of colorectal cancer screening programs with home-based digital counsellingFleur E Marijnissen, Elyse E C Rijnders, Merel M Tielemans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2015
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction studyW Kreuz, C Escuriola Ettingshausen, V Vdovin, et al.
Pageof 167

Showing results (1501-1510 of 1,668) with videos related to

Sort By:
Pageof 167
Endoscopy|July 6, 2025
Two-sample fecal immunochemical testing as a tool to avert colonoscopy in symptomatic patients: a prospective multicenter cohort studySarah Moen, Pieter H A Wisse, Fleur Marijnissen, et al.
The Lancet. Gastroenterology & Hepatology|February 3, 2023
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trialReinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
Molecular Oncology|July 28, 2019
RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancerErik J van Helden, Lindsay Angus, C Willemien Menke-van der Houven van Oordt, et al.
NPJ Precision Oncology|November 6, 2022
Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patientsTessa J J de Bitter, Philip R de Reuver, Elise A J de Savornin Lohman, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2022
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysisFrederik O Meeuwes, Mirian Brink, Marjolein W M van der Poel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2021
IL-7 and IL-15 Levels Reflect the Degree of T Cell Depletion during Lymphopenia and Are Associated with an Expansion of Effector Memory T Cells after Pediatric Hematopoietic Stem Cell TransplantationKatrine Kielsen, Lisa V E Oostenbrink, Erik G J von Asmuth, et al.
Breast Cancer Research and Treatment|March 4, 2008
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifenMarleen Kok, Sabine C Linn, Ryan K Van Laar, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
NPJ Digital Medicine|May 15, 2025
Reducing outpatient visits for FIT-positive participants of colorectal cancer screening programs with home-based digital counsellingFleur E Marijnissen, Elyse E C Rijnders, Merel M Tielemans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2015
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction studyW Kreuz, C Escuriola Ettingshausen, V Vdovin, et al.
Pageof 167